Parietal-hippocampal rTMS improves cognitive function in Alzheimer's disease and increases dynamic functional connectivity of default mode network

•A double-blind, randomized, sham-controlled, fMRI-guided rTMS trial.•Individualized rTMS over the parietal region is effective in treating Alzheimer's disease.•fMRI-guided rTMS treatment improves patients’ cognitive performance.•fMRI-guided rTMS treatment enhances functional connectivity of DM...

Full description

Saved in:
Bibliographic Details
Published inPsychiatry research Vol. 315; p. 114721
Main Authors Wei, Lili, Zhang, Yingchun, Wang, Jintao, Xu, Luoyi, Yang, Kehua, Lv, Xinghui, Zhu, Zhenwei, Gong, Qian, Hu, Weiming, Li, Xia, Qian, Mincai, Shen, Yuedi, Chen, Wei
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•A double-blind, randomized, sham-controlled, fMRI-guided rTMS trial.•Individualized rTMS over the parietal region is effective in treating Alzheimer's disease.•fMRI-guided rTMS treatment improves patients’ cognitive performance.•fMRI-guided rTMS treatment enhances functional connectivity of DMN.•IMPROVED cognitive function is related to enhanced DMN functional connectivity. Parietal-hippocampal repetitive transcranial magnetic stimulation (rTMS) improves cognitive function in Alzheimer's disease (AD), however, the underlying therapeutic mechanism has not been elucidated. A double-blind, randomized, sham-controlled parietal-hippocampal rTMS trial (five sessions/week for a total of 10 sessions) of mild-to-moderate AD patients was conducted in the study. High-frequency rTMS was applied to a subject-specific left lateral parietal region with the highest functional connectivity with the hippocampus based on resting-state fMRI. A multimodal MRI scan and a complete neuropsychological battery of tests were conducted at baseline, immediately after the intervention and 12-week follow-up after the rTMS treatment. Compared to sham treatment (n = 27), patients undergoing active rTMS treatment (n = 29) showed higher Mini Mental State Examination (MMSE) score and dynamic functional connectivity (dFC) magnitude of the default mode network (DMN) after two weeks of rTMS treatment, but not at 12-week follow-up. A significant positive correlation was observed between changes in MMSE and changes in the dFC magnitude of DMN in patients who underwent active-rTMS treatment, but not in those who received sham-rTMS treatment. The findings of the current study indicate that fMRI-guided rTMS treatment improves cognitive function of AD patients in the short term, and DMN functional connectivity contributes to therapeutic effectiveness of rTMS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0165-1781
1872-7123
1872-7123
DOI:10.1016/j.psychres.2022.114721